批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 1992/11/16 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2025/03/05 |
SUPPL-44(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2024/08/14 |
SUPPL-42(补充) |
Approval |
Labeling-Container/Carton Labels |
STANDARD
|
|
|
| 2024/07/23 |
SUPPL-43(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2024/01/26 |
SUPPL-40(补充) |
Approval |
Labeling-Medication Guide,Labeling-Package Insert |
STANDARD
|
|
|
| 2022/11/28 |
SUPPL-37(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2020/12/19 |
SUPPL-35(补充) |
Approval |
Efficacy-New Patient Population |
STANDARD
|
|
|
| 2018/04/26 |
SUPPL-28(补充) |
Approval |
Labeling-Medication Guide,Labeling-Package Insert |
STANDARD
|
|
|
| 2017/09/15 |
SUPPL-27(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2013/08/13 |
SUPPL-26(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2010/12/20 |
SUPPL-24(补充) |
Approval |
Labeling-Package Insert |
UNKNOWN
|
|
|
| 2007/09/04 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2002/09/30 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2002/09/30 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2002/06/03 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2001/07/19 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2001/03/09 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2001/01/24 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 1998/04/02 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 1997/06/13 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 1997/06/13 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 1997/04/08 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1997/01/29 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 1996/10/08 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1996/02/01 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1995/05/08 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 1994/11/21 |
SUPPL-2(补充) |
Approval |
Efficacy-New Indication |
UNKNOWN
|
|
|
| 1994/11/21 |
SUPPL-1(补充) |
Approval |
Efficacy-New Indication |
UNKNOWN
|
|
|
| 1993/10/26 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
>>>活性成分:GADOTERIDOL; 剂型/给药途径:INJECTABLE;INJECTION; 规格:279.3MG/ML; 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 020131 |
001 |
NDA |
PROHANCE |
GADOTERIDOL |
INJECTABLE;INJECTION |
279.3MG/ML |
Prescription |
Yes |
Yes |
AP |
1992/11/16
|
BRACCO |
| 218749 |
001 |
ANDA |
GADOTERIDOL |
GADOTERIDOL |
INJECTABLE;INJECTION |
279.3MG/ML |
Prescription |
No |
No |
AP |
2025/02/11
|
HAINAN POLY |